Skip to content
Wenlo
Sign in
← Markets

GeneDx Holdings Corp.

Kevin Feeley (CHIEF FINANCIAL OFFICER) sells WGS shares

4WGSFiled Sep 18, 2026, 12:39 PM ET· Period Sep 16, 2026

About this filing

GeneDx Holdings Corp. (WGS) filed Form 4 (insider transaction) with the SEC on Sep 18, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Kevin Feeley · CHIEF FINANCIAL OFFICER
DateTransactionSharesPriceValueHeld afterOwnership
Sep 16, 2026M · exercise or conversion of a derivativeFootnotes F1+7,197$0.00$0.0048,673Direct
Sep 16, 2026S · open-market saleFootnotes F2, F3−586$94.26$55,235.1948,087Direct
Sep 16, 2026S · open-market saleFootnotes F2, F4−52$95.41$4,961.0648,035Direct
Sep 16, 2026S · open-market saleFootnotes F2, F5−541$96.90$52,423.3947,494Direct
Sep 16, 2026S · open-market saleFootnotes F2, F6−1,470$98.27$144,456.9046,024Direct
Sep 16, 2026S · open-market saleFootnotes F2, F7, F8−1,079$99.00$106,815.6144,945Direct
Sep 16, 2026M · exercise or conversion of a derivativeRestricted Stock UnitFootnotes F1, F9−7,197$0.00$0.0014,393Direct
Footnotes
  1. F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
  2. F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  3. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.23 to $94.855 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4.
  4. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.29 to $95.52 per share, inclusive.
  5. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.445 to $97.40 per share, inclusive.
  6. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.565 to $98.535 per share, inclusive.
  7. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.60 to $99.305 per share, inclusive.
  8. F8 Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 44,945 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 71,667 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
  9. F9 6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

More WGS filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.